HomePublications

Can drug price hikes via debranding be prevented?

Research output: Contribution to journalArticle

Open Access permissions

Open

Documents

Links

DOI

Authors

Organisational units

Abstract

Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?

Details

Original languageEnglish
Pages (from-to)44-46
Number of pages3
JournalPrescriber
Volume28
Issue number4
DOIs
Publication statusPublished - 30 Apr 2017
Peer-reviewedNo

Downloads statistics

No data available

View graph of relations

ID: 110171169

Related by journal
  1. Effects of telephone counselling on mortality and adherence

    Research output: Contribution to journalArticle